Straumann Holding AG stock (CH0012280076): Leader in dental implants eyes US growth

Straumann Holding AG, a Swiss dental implant specialist, continues to expand in the US market with strong implant sales driving revenue. Recent financials show robust growth amid rising demand for aesthetic dentistry solutions.

Straumann Holding AG, a global leader in dental implants and biomaterials, reported continued revenue growth in its latest financial update. The company, listed on the SIX Swiss Exchange, benefits from increasing demand for premium dental solutions in North America, including the US. Shares have shown resilience amid sector tailwinds.

As of: 11.05.2026

By the editorial team – specialized in equity coverage.

At a glance

• Name: Straumann Holding AG
• Sector/industry: Dental equipment and biomaterials
• Headquarters/country: Basel, Switzerland
• Core markets: Europe, North America, Asia-Pacific
• Key revenue drivers: Implants, clear aligners, biomaterials
• Home exchange/listing venue: SIX Swiss Exchange (RO)
• Trading currency: CHF

Straumann Holding AG: core business model

Straumann Holding AG develops, manufactures and distributes dental implants, restorative products and biomaterials. Founded in 1954, the company pioneered titanium implants and now offers a full range of solutions for tooth replacement and orthodontics. Its portfolio includes the Straumann Dental Implant System, BLX implants for immediate treatment, and digital workflows via the Straumann Group ecosystem.

The business model focuses on premium products sold through a network of over 130 sales organizations worldwide. Straumann emphasizes innovation, with R&D investments supporting regenerative therapies like Emdogain and Roxolid material. Revenue is generated via direct sales to clinics and distribution partnerships, with a strong emphasis on training for dental professionals.

Main revenue and product drivers for Straumann Holding AG

Implants account for the largest revenue share, comprising over 50% of sales according to the full-year 2023 report published on Straumann IR as of March 2024. Clear aligners and CADCAM solutions have grown rapidly, driven by the shift to digital dentistry. Biomaterials and tissue regeneration products contribute steady growth.

Geographically, EMEA generates about 40% of revenue, followed by North America at around 25% and Asia-Pacific. US exposure is significant through direct operations and partnerships, benefiting from an aging population and aesthetic dentistry trends. The stock traded at approximately 120 CHF on SIX as of early 2026 data from exchange records.

Industry trends and competitive position

The global dental implant market is projected to grow at 8-10% CAGR through 2030, fueled by rising implant adoption and digital tools, per sector reports. Straumann holds a leading position with a 20-25% global market share in premium implants. Competitors include Nobel Biocare (Envista), Dentsply Sirona and Zimmer Biomet.

Straumann differentiates through its open ecosystem, allowing integration with third-party scanners and mills. Recent expansions include the 2023 acquisition of maxon group for medtech expertise, enhancing digital capabilities. For US investors, Straumann offers exposure to a defensive healthcare subsector with stable demand.

Why Straumann Holding AG matters for US investors

Straumann's North American segment has shown double-digit growth, driven by US clinic expansions and premium product penetration. The company serves a vast US dental market valued at over $150 billion annually. Listing on SIX provides US retail investors access via ADRs or direct trading on international brokers.

With US healthcare spending on dentistry rising post-pandemic, Straumann's focus on aesthetics and immediacy aligns with consumer trends. Its CHF-denominated shares offer currency diversification for US portfolios.

Conclusion

Straumann Holding AG maintains a strong position in the dental implant market with diversified revenue streams and global reach. Ongoing innovation and US market growth provide tailwinds, while premium pricing supports margins. Investors track upcoming earnings for guidance on digital and aligner segments.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.